Umngcunube

Umxholo

• Inokwenzeka ukuba isebenze ...
• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

I-Willow bark yi-bark evela kwiindidi ezahlukeneyo zomthi womngcunube, kubandakanya umngcunube omhlophe okanye umngcunube waseYurophu, umngcunube omnyama okanye umngxunya, Amaxolo asetyenziselwa ukwenza iyeza.

I-Willow bark isebenza kakhulu njenge-aspirin. Kuqhelekileyo kusetyenziswa iintlungu kunye nomkhuhlane. Kodwa abukho ubungqina benzululwazi obubonisa ukuba iyasebenza kunye neasprini kwezi meko.

Isifo seCoronavirus 2019 (COVID-19): Ezinye iingcali zilumkisa ukuba i-willow bark inokuphazamisa impendulo yomzimba ngokuchasene ne-COVID-19. Akukho datha inamandla yokuxhasa esi silumkiso. Kodwa akukho datha ilungileyo yokuxhasa usebenzisa i-willow bark ye-COVID-19.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe UWELLOW BARK zezi zilandelayo:

Inokwenzeka ukuba isebenze ...

• Umqolo obuhlungu. I-Willow bark ibonakala inciphisa iintlungu ezisezantsi. Iidosi eziphezulu zibonakala zisebenza ngakumbi kunedosi ezisezantsi. Ingathatha ukuya kwiveki yokuphucuka okubonakalayo.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Osteoarthritis. Uphando malunga ne-willow bark ekhutshwe i-osteoarthritis ivelise iziphumo eziphikisanayo. Olunye uphando lubonisa ukuba lunokunciphisa iintlungu ze-osteoarthritis. Ngapha koko, bukhona ubungqina obucebisa ukuba i-willow bark extract isebenza kunye namayeza aqhelekileyo e-osteoarthritis. Kodwa olunye uphando alubonisi sibonelelo.
• Isifo samathambo (RA). Uphando lwakwangoko lubonisa ukuba i-willow bark extract ayinciphisi iintlungu kubantu abane-RA.
• Uhlobo lwe-arthritis oluchaphazela kakhulu umqolo (i-ankylosing spondylitis).
• Okubandayo Okunye.
• Ifiva.
• Umkhuhlane (umkhuhlane).
• Igawuthi.
• Intloko ebuhlungu.
• Intlungu edibeneyo.
• Ukuxhuzula kokuya exesheni (idysmenorrhea).
• Intlungu yezihlunu.
• Ukutyeba kakhulu.
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala ukusebenza kwe-willow bark kwezi zinto zisetyenziswayo.

I-Willow bark inekhemikhali ebizwa ngokuba yi-salicin efanayo ne-aspirin.

Xa kuthathwa ngomlomo: Umthi womngcunube ngu UKHUSELEKO OLUNOKWENZEKA kubantu abadala xa bethathwe ukuya kuthi ga kwiiveki ezili-12. Ingabangela iintloko, isisu, kunye nenkqubo yokugaya ukutya. Inokubangela ukurhawuzelela, irhashalala, kunye nokuphazamiseka komzimba, ngakumbi kubantu i-aspirin.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa: Akukho lwazi lwaneleyo lunokuthenjwa lokwazi ukuba ngaba i-willow bark ikhuselekile ukuba ingasetyenziswa xa ukhulelwe. Hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa.

Ukuncancisa: Sebenzisa amaxolo omngcunube ngexa uncancisa OKUNGENZEKA UKHUSELEKILE. I-Willow bark iqulethe imichiza enokungena kubisi lwebele kwaye ibe neziphumo ezinobungozi kusana olunyisayo. Sukuyisebenzisa ukuba uncancisa.

Abantwana: Umthi womngcunube ngu OKUNGENZEKA UKHUSELEKILE n abantwana xa bethathwe ngomlomo ukusuleleka kwintsholongwane njengengqele kunye nomkhuhlane. Kukho inkxalabo yokuba, njenge-aspirin, inokunyusa umngcipheko wokuba ne-Reye's syndrome. Hlala kwicala elikhuselekileyo kwaye ungasebenzisi i-willow bark kubantwana.

Iingxaki zokopha: I-Willow bark inokunyusa umngcipheko wokopha kubantu abanengxaki yokopha.

Isifo sezintso: I-Willow bark inokunciphisa ukuhamba kwegazi kwizintso. Oku kunokukhokelela ekusileleni kwezintso kwabanye abantu. Ukuba unesifo sezintso, musa ukusebenzisa i-willow bark.

Ubuntununtunu kwi-aspirin: Abantu abane-ASTHMA, IZILONDA ZESISU, ISIFO SESWEBHILE, IGOUT, I-HEMOPHILIA, I-HYPOPROTHROMBINEMIA, okanye i-KIDNEY okanye i-LIVER ISIFO banokuba novakalelo kwi-aspirin kunye ne-willow bark. Ukusebenzisa i-willow bark kunokubangela ukungabikho komzimba. Kuphephe ukusebenzisa.

Ugqirha: Umthi womngcunube unokucothisa ukopha kwegazi. Kukho inkxalabo enokubangela ukopha ngakumbi ngexesha nasemva kotyando. Yeka ukusebenzisa i-willow bark ubuncinci kwiiveki ezi-2 ngaphambi kotyando olucwangcisiweyo.

Mkhulu

Sukuyithatha le indibaniselwano.

Amayeza acothisa ukujiya kwegazi (iAnticoagulant / iziyobisi zeAntiplatelet)

Ukukhonkotha kweWillow kunokunciphisa ukucima igazi. Ukuthatha i-willow bark kunye namayeza anciphisa ukujiya kwegazi kunokwandisa amathuba okugruzuka nokopha.

Amanye amayeza acothisa ukucoca igazi aquka iasprini, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, abanye), ibuprofen (Advil, Motrin, abanye), naproxen (Anaprox, Naprosyn, abanye), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), kunye nezinye.

Iphakathi

Lumka ngale nhlanganisela.

Acetazolamide

I-Willow bark iqulethe iikhemikhali ezinokunyusa inani le-acetazolamide egazini. Ukuthatha i-willow bark kunye ne-acetazolamide kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga ze-acetazolamide.

I-Aspirin

I-Willow bark iqulethe imichiza efana ne-aspirin. Ukuthatha i-willow bark kunye ne-aspirin kunokunyusa iziphumo kunye neempembelelo ze-aspirin.

I-Choline Magnesium Trisalicylate (iTrilisate)

I-Willow bark iqulethe iikhemikhali ezifanayo ne-choline magnesium trisalicylate (Trilisate). Ukuthatha i-willow bark kunye ne-choline magnesium trisalicylate (Trilisate) kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga ze-choline magnesium trisalicylate (Trilisate).

Isalalate (Disalcid)

I-Salsalate (Disalcid) luhlobo lonyango olubizwa ngokuba yi-salicylate. Iyafana neasprini. I-Willow bark iqulethe i-salicylate efanayo ne-aspirin. Ukuthatha i-salsalate (Disalcid) kunye ne-willow bark kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga ze-salsalate (Disalcid).

Iherbs kunye nezongezo ezinokucothisa igazi

Umthi womngcunube unokucothisa ukujiya kwegazi. Ukuyisebenzisa kunye namanye amayeza anokucothisa ukujiya kwegazi kunokunyusa amathuba okuphuma kwegazi kunye nokugruzuka kwabanye abantu. Ezi zityalo zibandakanya i-clove, i-danshen, igalikhi, ijinja, iginkgo, i-ginseng, i-meadowsweet, i-clover ebomvu kunye nezinye.

Iitrob ezinemichiza efana neasprini (salicylates)

I-Willow bark iqulethe imichiza efana neekhemikhali ezifana ne-aspirin ebizwa ngokuba yi-salicylate. Ukuthatha i-willow bark kunye namayeza aqukethe i-salicylate kunokunyusa iziphumo ze-salicylate kunye neziphumo ezibi. Imifuno enesalicylate ibandakanya i-aspen bark, i-black haw, ipoplar kunye ne-meadowsweet.

Akukho kunxibelelana kwaziwayo nokutya.

La machiza alandelayo afundwe kuphando lwezesayensi:

NGOMLOMO:

• Kwiintlungu zomqoloKusetyenziswe i-Willow bark ukubonelela nge-120-240 mg salicin. Idosi ephezulu ye-240 mg inokusebenza ngakumbi.

Basket Willow, Bay Willow, Black Willow, Black Willow, Brittle Willow, Corteza de Sauce, Crack Willow, Daphne Willow, Écorce de Saule, decorce de Saule Blanc, European Willow, European Willow Bark, Extrait d'itcorce de Saule, Isongezelelo d'Écorce de Saule Blanc, Extrait de Saule, Extrait de Saule Blanc, Knackweide, Laurel Willow, Lorbeerweide, Organic Willow, Osier Blanc, Osier Rouge, Purple Osier, Purple Osier Willow, Purple Willow, Purpurweide, Pussy Willow, Reifweide Cortex, Salix alba, Salix babylonica, Salix daphnoides, Salix fragilis, Salix nigra, Salix pentandra, Salix purpurea, Saule, Saule Argenté, Saule Blanc, Saule Commun, Saule des Viviers, Saule Discolore, Saule Fragile, Saule Noir, Saule Noir, Silberweide, Violet Willow, Weidenrinde, White Willow, White Willow Bark, Willowbark, White Willow Caphula, Willow Bark Caphula.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. UWuthold K, Germann I, Roos G, et al. Umaleko obhityileyo we-chromatografi kunye nohlalutyo lwedatha ye-willow bark extracts. J Chromatogr Sci. Ngo-2004; 42: 306-9. Jonga i-abstract.
2. Uehleke B, Müller J, Stange R, Kelber O, Melzer J. Willow bark ukukhupha i-STW 33-I kunyango lwexesha elide labalaliswa ngaphandle kunye nentlungu ye-rheumatic ikakhulu i-osteoarthritis okanye umqolo obuhlungu. Unyango lwezonyango. Ngo-2013 Agasti 15; 20: 980-4. Jonga i-abstract.
3. I-Beer AM, i-Wegener T. Willow bark isicatshulwa (i-Salicis cortex) ye-gonarthrosis kunye ne-coxarthrosis-iziphumo zesifundo seqela kunye neqela lolawulo. Unyango lwezonyango. NgoNovemba 2008; 15: 907-13. Jonga i-abstract.
4. I-Nieman DC, i-Shanely RA, i-Luo B, i-Dew D, i-MP ye-Meaney, i-Sha W. Isongezelelo sokutya esithengiswayo sinciphisa intlungu edibeneyo kubantu abadala: ityala elilawulwa yi-placebo. Isondlo J 2013; 12: 154. Jonga i-abstract.
5. UGagnier JJ, uVanTulder MW, uBerman B, kunye no-al. Iyeza leBotanical leentlungu ezisezantsi: uphononongo lwenkqubo [abstract]. I-9th Symposium yoNyaka yoNonophelo lwezeMpilo oluNcedisayo, nge-4 ka-Disemba 6, e-Exter, e-UK 2002.
6. UWerner G, uMarz RW, kunye no-Schremmer D. Assalix weentlungu ezingapheliyo zangasemva kunye ne-arthralgia: Uhlalutyo lwethutyana lophando lokujonga ukuthengisa. Isimpoziyam yesi-8 yoNyaka yoNonophelo lwezeMpilo eQinisekisiweyo, nge-6 - 8 kuDisemba 2001.
7. I-CV encinci, iiParsons T, kunye neLogan S. Unyango lwe-Herbal yokunyanga i-osteoarthritis. Ithala leencwadi laseCochrane 2002; 1.
8. I-Loniewski I, i-Glinko A, kunye ne-Samochowiec L. Imigangatho yomthi womngcunube emiselweyo: iyeza elinamandla lokulwa nokudumba. Isimpoziyam yoNyaka yesi-8 yoNonophelo lwezeMpilo eQinisekisiweyo, nge-8 ukuya kwe-8 kuDisemba 2001.
9. I-Schaffner W. Eidenrinde-ein antiarrheumatikum der yanamhlanje iPhytotherapie? Ngo-1997; 125-127.
10. Mnyama A, Künzel O, Chrubasik S, kunye et al. Uqoqosho lokusebenzisa i-willow bark ekhutshwe kunyango lwangaphandle lweentlungu ezisezantsi [ezingabonakaliyo]. Isimpoziyam yoNyaka yesi-8 yoNonophelo lwezeMpilo eQinisekisiweyo, nge-8 ukuya kwe-8 kuDisemba 2001.
11. IChrubasik S, Künzel O, Imodeli A, kunye et al. I-Assalix® vs Vioxx® yeentlungu ezisezantsi-isifundo esilawulwa ngokungahleliwe. Isimpoziyam yoNyaka yesi-8 yoNonophelo lwezeMpilo eQinisekisiweyo, nge-6 - 8 kuDisemba 2001.
12. Meier B, Shao Y, Julkunen-Tiitto R, kunye et al. Uvavanyo lwe-chemotaxonomic lwee-phenolic compounds kwiintlobo ze-Swiss willow. Planta Medica 1992; 58 (suppl 1): A698.
13. IHyson MI. I-anticephalgic photoprotective pre-preated mask. Ingxelo yesifundo esilawulwa ngempumelelo esingaboniyo esilawulwa yi-placebo sonyango olutsha lweentloko ezinentlungu yangaphambili kunye ne-photophobia. Intloko ye1998; 38: 475-477.
14. USteinegger, E. noHovel, H. [Uhlalutyo kunye nezifundo zebhayoloji kwizinto zeSalicaceae, ngokukodwa kwi-salicin. II. Uphononongo lwebhayoloji]. Ugqirha Acta Helv. Ngo-1972; 47: 222-234. Jonga i-abstract.
15. Sweeney, K. R., Chapron, D. J., Brandt, J. L., Gomolin, I.H, Feig, P. U., kunye noKramer, P. A.Ukuhlangana okunetyhefu phakathi kwe-acetazolamide kunye ne-salicylate: iingxelo zamatyala kunye nengcaciso ye-pharmacokinetic. KwiKlinikhi ye-Pharmacol Ther 1986; 40: 518-524. Jonga i-abstract.

16. Moro PA, Flacco V, Cassetti F, Clementi V, Colombo ML, Chiesa GM, Menniti-Ippolito F, Raschetti R, Santuccio C. Hypovolemic shock ngenxa yokopha ngamandla esiswini emntwaneni othatha isiraphu yemifuno. UAnn Ist Super Sanita. Ngo-2011; 47: 278-83.

    
    
    Jonga i-abstract.
17. Cameron, M., Gagnier, J. J., Little, C. V., Parsons, T. J., Blumle, A., noChrubasik, S. Ubungqina bokusebenza kweemveliso zamayeza ezonyango kunyango lwe-arthritis. Icandelo I: Osteoarthritis. Phytother.Res 2009; 23: 1497-1515. Jonga i-abstract.

18. I-Kenstaviciene P, i-Nenortiene P, i-Kiliuviene G, i-Zevzikovas A, i-Lukosius A, i-Kazlauskiene D. Ukusetyenziswa kwe-chromatography engamanzi ephezulu kuphando lwe-salicin kwi-bark yeentlobo ezahlukeneyo ze-Salix. Unyango (Kaunas). Ngo-2009; 45: 644-51.

    Jonga i-abstract.

19. UVlachojannis JE, uCameron M, uChrubasik S.Uphononongo olucwangcisiweyo malunga nokusebenza kwe-willow bark ye-musculoskeletal pain. Phytother Res. NgoJulayi 2009; 23: 897-900.

    Jonga i-abstract.

20. UNahrstedt A, uSchmidt M, uJäggi R, uMetz J, uKhayyal MT. Ukukhupha i-Willow bark: igalelo leepolphenol kwisiphumo sisonke. IWien Med Wochenschr. Ngo-2007; 157 (13-14): 348-51.

    Jonga i-abstract.
21. Khayyal, M.T, El Ghazaly, M. A., Abdallah, D. M., Okpanyi, S. N., Kelber, O., kunye no-Weiser, D. Iindlela ezichaphazelekayo kwimpembelelo echasene nokuvuvukala kwesicatshulwa esimiselweyo somthi we-willow. IArzneimittelforschung 2005; 55: 677-687. Jonga i-abstract.
22. UKammerer, B., Kahlich, R., Biegert, C., Gleiter, C.H, noHeide, L. HPLC-MS / MS uhlalutyo lwezikhukhula ze-willow bark eziqulethwe kumalungiselelo amayeza. Uhlalutyo lwePhytochem. Ngo-2005; 16: 470-478. Jonga i-abstract.
23. UClauson, K. A., Santamarina, M. L., Buettner, C. M., kunye noCauffield, J. S. Uvavanyo lobukho bezilumkiso ezinxulumene ne-aspirin kunye ne-willow bark. UAnn Pharmacother. Ngo-2005; 39 (7-8): 1234-1237. Jonga i-abstract.
24. U-Akao, T., Yoshino, T., Kobashi, K., noHattori, M. Uvavanyo lwe-salicin njengeprodrug ye-antipyretic engabangeli ukwenzakala kwesisu. IPlanta Med 2002; 68: 714-718. Jonga i-abstract.
25. UChrubasik, S., Kunzel, O., Mnyama, A., uConradt, uC., NoKerschbaumer, F. Impembelelo yezoqoqosho enokubakho yokusebenzisa i-willow ye-bark bark ekhutshwe kunyango lwangaphandle lweentlungu ezisezantsi: isifundo esivulekileyo esingacwangciswanga. Unyango lwe-2001; 8: 241-251. Jonga i-abstract.

26. I-CV encinci, iParsons T. Unyango lwe-Herbal yokunyanga i-osteoarthritis. Isiseko sedatha yeCochrane Isityhi 2001; CD002947.

    Jonga i-abstract.
27. UChrubasik, J. E., Roufogalis, B. D., noChrubasik, S. Ubungqina bokusebenza kakuhle kwamachiza okunyanga amayeza kunyango lwe-osteoarthritis ebuhlungu kunye nentlungu engapheliyo. UPhytother Res 2007; 21: 675-683. Jonga i-abstract.
28. UGagnier, J. J., van Tulder, M., Berman, B., kunye neBombardier, C. Amayeza e-Herbal ngenxa yeentlungu ezisezantsi. Idatha yedatha yeCochrane. Ngo-2006; CD004504. Jonga i-abstract.
29. I-Mills SY, uJacoby RK, uChacksfield M, uWilloughby M.Ukusebenza kwamayeza e-herbal ekuxhaseni iintlungu ezinganyangekiyo: isifundo esingaboni kabini. UBr J Rheumatol 1996; 35: 874-8. Jonga i-abstract.
30. U-Ernst, E. kunye noChrubasik, S. Phyto-anti-inflammatories. Uphengululo olucwangcisiweyo lokuvavanywa ngokungalawulekiyo, olulawulwa yi-placebo, iimvavanyo ezingaboni kabini. Rheum.Dis Ikliniki yaseNyakatho Am 2000; 26: 13-27, vii. Jonga i-abstract.
31. UGagnier JJ, van Tulder MW, Berman B, Bombardier C. Amayeza e-Herbal kwiintlungu ezisezantsi. Uphengululo lweCochrane. Isihlwele 2007; 32: 82-92. Jonga i-abstract.
32. I-Fiebich BL, i-Appel K. Iziphumo ezichasayo ezichasayo zokukhupha i-willow bark. Kwiklinikhi ye-Pharmacol Ther 2003; 74: 96. Jonga i-abstract.
33. ICoffey CS, uSteiner D, uBaker BA, uAllison DB. Uvavanyo lweklinikhi olulawulwa kabini olungenamfama olulawulwa yimveliso equlathe i-ephedrine, icaffeine, kunye nezinye izithako ezivela kwimithombo yamayeza kunyango lokutyeba kakhulu kunye nokutyeba kakhulu ekungabikho kwendlela yokuphila. I-Int J Obes edibanisa iMetab Disord 2004; 28: 1411-9. Jonga i-abstract.
34. UKrivoy N, uPavlotzky E, uChrubasik S, et al. Iziphumo zokukhutshwa kwe-salicis cortex kwiflatelet yabantu. IPlanta Med 2001; 67: 209-12. Jonga i-abstract.
35. UWagner I, uGreim C, uLaufer S, okqhubekayo. Impembelelo ye-willow bark ekhutshwe kwimisebenzi ye-cyclooxygenase nakwi-tumor necrosis factor alpha okanye i-interleukin 1 ukukhutshwa kwe-beta kwi-vitro nakwi-ex vivo. KwiKlinikhi ye-Pharmacol Ther 2003; 73: 272-4. Jonga i-abstract.
36. I-Schmid B, Kotter I, Heide L. Pharmacokinetics ye-salicin emva kolawulo lomlomo lwesiseko somthi we-willow omiselweyo. I-Eur J Clin Pharmacol. 2001; 57: 387-91. Jonga i-abstract.
37. Isifo sezintso sikaSchwarz A. Beethoven esekwe kwisidumbu sakhe: imeko ye-papillary necrosis. NdinguJ Kidney Dis 1993; 21: 643-52. Jonga i-abstract.
38. D'Agati V. Ngaba i-aspirin ibangela ukusilela okunamandla okanye okungapheliyo kwezintso kwizilwanyana zovavanyo nasebantwini? NdinguJ Kidney Dis 1996; 28: S24-9. Jonga i-abstract.
39. IChrubasik S, Kunzel O, Imodeli A, et al. Unyango lweentlungu ezisezantsi ezisezantsi kunye ne-herbal okanye i-synthetic anti-rheumatic: isifundo esilawulwa ngokungahleliwe. I-Willow bark ikhuphe iintlungu ezisezantsi. IRheumatology (Oxford) 2001; 40: 1388-93. Jonga i-abstract.
40. UClark JH, uWilson WG. Usana lweentsuku ezili-16 ezanyisayo olusana lwe-metabolic acidosis ebangelwa yi-salicylate. Iiklinikhi zezilwanyana (Phila) 1981; 20: 53-4. Jonga i-abstract.
41. Unsworth J, d'Assis-Fonseca A, Beswick DT, Blake DR.Amanqanaba eSalum salicylate kusana olusancancisayo. UAnn Rheum Dis 1987; 46: 638-9. Jonga i-abstract.
42. Ulawulo lokutya kunye neziyobisi, i-HHS. Ukuphawula iilebheli zomlomo kunye ne-rectal kwiimveliso ze-counter-counter eziqukethe i-aspirin kunye ne-nonaspirin salicylates; Isilumkiso sikaReye's Syndrome. Umthetho wokugqibela. Ukubhaliswa kweFed 2003; 68: 18861-9. Jonga i-abstract.
43. I-Fiebich BL, iChrubasik S.Iziphumo zokukhutshwa kwe-salix ye-ethanolic ekukhululweni kwabalamli abakhethiweyo abavuthayo kwi-vitro. Unyango lwe-Phytomedicine 2004; 11: 135-8. Jonga i-abstract.
44. Biegert C, Wagner I, Ludtke R, et al. Ukusebenza kunye nokukhuseleka kwe-willow bark ekhutshwe kunyango lwe-osteoarthritis kunye ne-rheumatoid arthritis: iziphumo zovavanyo olulawulwa kabini olungaboniyo. J Rheumatol 2004; 31: 2121-30. Jonga i-abstract.
45. USchmid B, uLudtke R, uSelbmann HK, okqhubekayo. Ukusebenza kunye nokunyamezeleka kwe-willow bark ekhutshwe kwizigulana ezine-osteoarthritis: ukulawulwa kwe-placebo ngokungalawulekiyo, uvavanyo lwezonyango olungaboniyo kabini. UPhytother Res 2001; 15: 344-50. Jonga i-abstract.
46. IBoullata JI, McDonnell PJ, i-CD yeOliva. Impendulo ye-Anaphylactic kwisongezelelo sokutya esine-willow bark. UAnn Pharmacother 2003; 37: 832-5 .. Jonga i-abstract.
47. Ulawulo lokutya kunye neziyobisi, i-HHS. Umthetho wokugqibela obhengeza izongezo zokutya eziqukethe i-ephedrine alkaloids engcolisiweyo kuba zibonisa umngcipheko ongekho ngqiqweni; Umthetho wokugqibela. Ubhaliso lweFed 2004; 69: 6787-6854. Jonga i-abstract.
48. UDulloo AG, uMiller DS. I-Ephedrine, icaffeine kunye neasprini: iziyobisi "ezingaphaya kwekhawuntare" ezisebenzisana ukukhuthaza i-thermogenesis etyebe kakhulu. Isondlo 1989; 5: 7-9.
49. IChrubasik S, i-Eisenberg E, i-Balan E, et al. Unyango lweentlungu ezisezantsi ezisezantsi kunye nokukhupha i-willow bark: isifundo esenziwe ngokungacwangciswanga esingaboniyo. NdinguJ Med 2000; 109: 9-14. Jonga i-abstract.
50. UDulloo AG, uMiller DS. I-Aspirin njengomkhuthazi we-ephedrine-induction thermogenesis: ukusetyenziswa okunokwenzeka kunyango lokutyeba kakhulu. NdinguJ J Clin Nutriti 1987; 45: 564-9. Jonga i-abstract.
51. IHorton TJ, uGeissler CA. I-Aspirin inokubangela isiphumo se-ephedrine kwimpendulo ye-thermogenic kwisidlo esityebileyo kodwa singoyiki. I-Int J Obes 1991; 15: 359-66. Jonga i-abstract.

Ukuhlaziywa okokugqibela-01/28/2021